MedTrace Logo

Feasibility Study of the TruSculpt Radiofrequency Device

NCT03018587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2023-03-07

Study results available
· View outcomes & findings →

Summary

A single-center, prospective, open-label feasibility study of the truSculpt radiofrequency device.

Conditions

  • Tissue Tightening

Interventions

DEVICE

TruSculpt

All subjects will receive 1 truSculpt radiofrequency treatment

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen Ronan, M.D. · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2017-12-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03018587 on ClinicalTrials.gov